pph prevention and management at health facilities jeffrey m. smith asia regional technical director...
TRANSCRIPT
PPH Prevention and Management at Health Facilities
Jeffrey M. SmithAsia Regional Technical Director
AME Regional MeetingBangkok March 2010
2
OBJECTIVES
Describe global guidance on postpartum hemorrhage prevention and management in health care facilities
Review specifically the provision of Active Management of Third Stage of Labor
Discuss policy and situational considerations for the implementation of PPH reduction strategies
3
A Pause for Epidemiology
Obstetric-Related Deaths per year
Maternal Deaths: 536,000 Neonatal Deaths: 3.4
million (most obstetrical)
Stillbirths: 4 million (most obstetrical)
Infectious Disease Deaths per year
HIV Deaths: 2 million TB Deaths: 1.6 million Malaria Deaths: 1.3
million
TOTAL Obstetrical Deaths per year = 6.5 million
TOTAL Infectious Disease Deaths per year = 5 million
4
Distribution of Maternal Deaths Asia Specific Distribution
Unclassified 6%
Other Indirect12%
Ectopic Preg0%
Embolism 0%
Other Direct
2%
Anaemia13%
Obstructed Labor9%
Abortion6%
Sepsis12%
Hypertensive9%
Haemorrhage31%
Haemorrhage
Hypertensive
Sepsis
Abortion
Obstructed Labor
Anaemia
Ectopic Preg
Embolism
Other Direct
Other Indirect
Unclassified
Khan, et al; WHO Analysis of Causes of Maternal Deaths; Lancet April 2006
5
Recommendations for PREVENTION of PPH in Health Care Facilities
Active management of third stage of labour (AMTSL) should be offered by all skilled attendants at every birth to prevent postpartum haemorrhage (PPH).
Oxytocin is the uterotonic of choice for prevention of PPH.
6
Evidence for AMTSL
AMTSL prevents PPH by over 60% (RR: 0.38,
95% CI 0.32-0.46) and therefore should be offered by all skilled birth attendants at every childbirth.
Oxytocin is the preferred drug because It is effective in 2-3 minutes after injection, has minimal side effects, can be used in all women, and is more stable in storage than ergometrine.
Oxytocin is the better choice than ergometrine or misoprostol, when all are available
7
Integrating the Steps for AMTSL
Integration of AMTSL with: Immediate newborn care Support for breastfeeding Immediate postplacental
insertion of IUCD Obstetrical emergencies
1. Give oxytocin immediately: Within 1 minute of birth of baby Oxytocin 10 units IM
2. Deliver the placenta by controlled cord traction Wait until cord pulsations cease
or 2-3 minutes Delayed cord clamping reduces
newborn and infant anemia
3. Massage the uterus Ensure uterine tone
Integrated Steps for AMTSL and Immediate Newborn Care: Skilled Birth Attendant With Oxytocin
Deb Armbruster and Sushie Engelbrecht, POPPHI Project
AMTSL and Breastfeeding
Bolus of oxytocic is necessary to achieve the strong contraction that helps separate placenta and establish good uterine tone
AMTSL helps achieve uterine tone Ongoing breastfeeding helps maintain uterine
tone Breastfeeding is an essential maternal/newborn
care practice, but not sufficient for AMTSL
9
10
AMTSL: A NECESSARY Part of Care for Normal Birth
Every birth should be attended by a skilled attendant
All national policies on skilled care during childbirth must include the provision of AMTSL
Every skilled birth attendant should be allowed to provide AMTSL
11
AMTSL: Who, How, Where?
Countries need to do an analysis of People who attend births and are
called “skilled attendants” Permission and ability of those
cadre to perform AMTSL Logistic systems that support
provision of oxytocin Policies and service delivery
frameworks that clearly state at which levels of the health care system skilled care, including AMTSL, can be provided.
HMIS/monitoring systems that track the implementation of AMTSL
PPH: Other causes and other prevention strategies
Causes Retained placenta Retained placental fragments Episiotomy and lacerations Uterine rupture
Prevention Strategies Partograph Avoid unnecessary episiotomy Inspection of placenta Inspection for lacerations Postpartum monitoring for
minimum of 6 hours
12
13
Afghanistan Yes
Bangladesh Yes
Cambodia Partial
East Timor Partial
Egypt Partial
India Partial
Indonesia Partial
Nepal Partial
Pakistan Partial
Palestine Partial
Philippines Partial
Vietnam Partial
Yemen Partial
Midwives and BEOC
Do policies allow midwives to provide a complete set of
BEOC interventions?
Align People, Services and Systems
14
Major Obstetrical
Killers
Global Definition
of Basic EOC
Policies and Clinical
Guidelines
Midwifery Job Description,
Competencies Capabilities and
Environment
Consistency and Alignment
Oxytocin in pre-filled Uniject™ device
• Uniject™ :
– Used in vaccines (HBV / tetanus) and contraceptives
– Validating / early introduction for oxytocin and gentamicin
• Oxytocin in Uniject™
– Studies in Indonesia, Angola,
Vietnam, and Mali have shown that
Uniject is:
– preferred by providers,
– units cannot be re-used, and
– utilization / storage /
elimination are easier Deb Armbruster and Sushie Engelbrecht,
POPPHI Project
Time-Temperature Indicator for Oxytocin in Uniject™
Chemical time and temperature cumulative exposure factor
Rate of color change calibrated by manufacturer based on stability studies
Advantages: Improvement in overall quality assurance of
programs – only effective oxytocin would be used
Flexible cold chain management Longer “out of cold chain” periods possible
than with other products Product can be available at peripheral
health facilities and for home births with skilled providers
Deb Armbruster and Sushie Engelbrecht, POPPHI Project
17
Management of PPH
Must be treated like an emergency Mobilize resources / staff Shout for help
General management Stabilize the patient Treat for shock
Determine the cause Specific management
Based on diagnosis
18
PPH Clinical Interventions
Basic EmOC Management of shock Uterotonics Bimanual compression Suturing of lacerations Aortic compression Manual removal of placenta Antishock garment
Comprehensive EmOC
Uterine artery ligation B-lynch procedure Hysterectomy Blood transfusion
19
Evidence regarding TREATMENT of PPH in Health Care Facilities:
Cochrane Review 2006 Search for pharmacological, surgical or
radiological interventions for the treatment of PPH
Insufficient data on surgical and radiological techniques
3 trials on use of misoprostol No proven benefit for reduction of
PPH, maternal mortality or surgery
New clinical trials on use of misoprostol 2006 - 2009 Some completed and ongoing trials by Gynuity and others suggest a
possible role for misoprostol in management of PPH
21
Conclusions
At health care facilities Prevention strategy is clear!
– AMTSL for all deliveries Management approach is less clear
– On-going studies to be followed
Need to consider not just technical interventions but also the programmatic approach ALL SBAs should be authorized and
trained to provide AMTSL and basic management of PPH
The best technical intervention is only the best when we can get it to the greatest number of people